Breakout Session 2A: Evidence-Based Treatment of Opioid Use Disorder in the Era of Fentanyl and Xylazine: What is Going On and What Can We Do About It? Session 1 (Day 2)

Description:

This session began with a 20-minute presentation by Dr. Sigmon on the scientific, epidemiologic, and clinical impacts of fentanyl and xylazine, followed by a 20-minute presentation by Mr. Childs on the real-world impacts, experiences, and lessons. It ended with a 20-minute Q&A period.

Presenters:

• Stacey Sigmon, PhD, MS, Professor of Psychiatry, University of Vermont
• Robert Childs, MPH, TEL, JBS International, Inc.